© 1997 by European Society of Cardiology
Copyright © 1997, European Society of Cardiology
Endothelial dysfunction and pathogenesis of diabetic angiopathy
aDepartment of Internal Medicine, Free University Hospital, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands
bInstitute for Cardiovascular Research, Free University Hospital, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands
cGaubius Laboratory, TNO Prevention and Health, 2301 CE Leiden, Netherlands
* Corresponding author. Tel. +31 20 4440531; Fax +31 20 4440502.
Objective and Methods: To review, from the clinical perspective, the contribution of dysfunction of the vascular endothelium to the pathogenesis of diabetic micro- and macroangiopathy. Results: Available data indicate that endothelial dysfunction in diabetes complicated by micro- or macroalbuminuria (renal microangiopathy) is generalised. The close linkage between microalbuminuria and endothelial dysfunction is an attractive explanation for the fact that microalbuminuria is a risk marker for atherosclerotic cardiovascular disease in diabetes. Endothelial dysfunction precedes the occurrence of even early diabetic microangiopathy. However, it is not clear whether endothelial dysfunction is a feature of the diabetic state per se or whether additional factors are required to induce endothelial dysfunction given the presence of diabetes. Convincing data from animal and in vitro models exist to indicate that endothelial dysfunction in diabetes may be related to hyperglycaemic pseudohypoxia, activation of protein kinase C, increased expression of transforming growth factor-β and vascular endothelial growth factor, non-enzymatic glycation, oxidative stress, activation of the coagulation cascade, increased expression of tumour necrosis factor-
, and high levels of insulin and insulin precursor molecules. However, the importance of these proposed mechanisms have not yet been extensively assessed in diabetes in man. Conclusions: Endothelial dysfunction plays a key role in the pathogenesis of diabetic angiopathy in man. The biochemical basis of endothelial dysfunction in diabetic man, however, has yet to be fully elucidated.
KEYWORDS Diabetes; Human; Endothelium; Diabetic angiopathy; Hyperglycemia; Insulin; Non-enzymatic glycation
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  T. T. Nguyen, R. Kawasaki, J. J. Wang, A. J. Kreis, J. Shaw, W. Vilser, and T. Y. Wong Flicker Light-Induced Retinal Vasodilation in Diabetes and Diabetic Retinopathy Diabetes Care, November 1, 2009; 32(11): 2075 - 2080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Bagi Mechanisms of coronary microvascular adaptation to obesity Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2009; 297(3): R556 - R567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Lopez-Lopez, J. Moral-Sanz, G. Frazziano, M. J. Gomez-Villalobos, J. Flores-Hernandez, E. Monjaraz, A. Cogolludo, and F. Perez-Vizcaino Diabetes induces pulmonary artery endothelial dysfunction by NADPH oxidase induction Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L727 - L732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wang, Q. Peng, J. Zhang, and L. Liu Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain Cardiovasc Res, November 1, 2008; 80(2): 255 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Singhania, D. Puri, S.V. Madhu, and S.B. Sharma Assessment of oxidative stress and endothelial dysfunction in Asian Indians with type 2 diabetes mellitus with and without macroangiopathy QJM, June 1, 2008; 101(6): 449 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A Brooks, S. V McLennan, S. M Twigg, and D. K Yue Detection and characterisation of microcirculatory abnormalities in the skin of diabetic patients with microvascular complications Diabetes and Vascular Disease Research, March 1, 2008; 5(1): 30 - 35. [Abstract] [PDF]
|
|
|
|
|
|
A. Mandecka, J. Dawczynski, M. Blum, N. Muller, C. Kloos, G. Wolf, W. Vilser, H. Hoyer, and U. A. Muller Influence of Flickering Light on the Retinal Vessels in Diabetic Patients Diabetes Care, December 1, 2007; 30(12): 3048 - 3052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L Browne, D. R Meeking, S. Allard, L. J Munday, K. M Shaw, and M. H Cummings Vasodilator prostanoids compensate for attenuated nitric oxide mediated vasodilation in type 1 diabetes The British Journal of Diabetes & Vascular Disease, November 1, 2007; 7(6): 288 - 294. [Abstract] [PDF]
|
|
|
|
 |
|
 N. Erdei, Z. Bagi, I. Edes, G. Kaley, and A. Koller H2O2 increases production of constrictor prostaglandins in smooth muscle leading to enhanced arteriolar tone in Type 2 diabetic mice Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H649 - H656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Erdei, A. Toth, E. T. Pasztor, Z. Papp, I. Edes, A. Koller, and Z. Bagi High-fat diet-induced reduction in nitric oxide-dependent arteriolar dilation in rats: role of xanthine oxidase-derived superoxide anion Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2107 - H2115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Brassard, A. Ferland, V. Gaudreault, N. Bonneville, J. Jobin, and P. Poirier Elevated peak exercise systolic blood pressure is not associated with reduced exercise capacity in subjects with Type 2 diabetes J Appl Physiol, September 1, 2006; 101(3): 893 - 897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. de Jager, J. M. Dekker, A. Kooy, P. J. Kostense, G. Nijpels, R. J. Heine, L. M. Bouter, and C. D.A. Stehouwer Endothelial Dysfunction and Low-Grade Inflammation Explain Much of the Excess Cardiovascular Mortality in Individuals With Type 2 Diabetes: The Hoorn Study Arterioscler Thromb Vasc Biol, May 1, 2006; 26(5): 1086 - 1093. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Meigs, C. J. O'Donnell, G. H. Tofler, E. J. Benjamin, C. S. Fox, I. Lipinska, D. M. Nathan, L. M. Sullivan, R. B. D'Agostino, and P. W.F. Wilson Hemostatic Markers of Endothelial Dysfunction and Risk of Incident Type 2 Diabetes: The Framingham Offspring Study Diabetes, February 1, 2006; 55(2): 530 - 537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Thorand, J. Baumert, L. Chambless, C. Meisinger, H. Kolb, A. Doring, H. Lowel, W. Koenig, and for the MONICA/KORA Study Group Elevated Markers of Endothelial Dysfunction Predict Type 2 Diabetes Mellitus in Middle-Aged Men and Women From the General Population Arterioscler Thromb Vasc Biol, February 1, 2006; 26(2): 398 - 405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Xu, E. T Lee, L. G Best, M. Begum, W. C Knowler, R. R Fabsitz, and B. V Howard Association of albuminuria with all-cause and cardiovascular disease mortality in diabetes: the Strong Heart Study The British Journal of Diabetes & Vascular Disease, November 1, 2005; 5(6): 334 - 340. [Abstract] [PDF]
|
|
|
|
|
|
Z. Bagi, N. Erdei, A. Toth, W. Li, T. H. Hintze, A. Koller, and G. Kaley Type 2 Diabetic Mice Have Increased Arteriolar Tone and Blood Pressure: Enhanced Release of COX-2-Derived Constrictor Prostaglandins Arterioscler Thromb Vasc Biol, August 1, 2005; 25(8): 1610 - 1616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. S. Lim, A. D. Blann, A. Y. Chong, B. Freestone, and G. Y.H. Lip Plasma Vascular Endothelial Growth Factor, Angiopoietin-1, and Angiopoietin-2 in Diabetes: Implications for cardiovascular risk and effects of multifactorial intervention Diabetes Care, December 1, 2004; 27(12): 2918 - 2924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Bagi, E. Toth, A. Koller, and G. Kaley Microvascular dysfunction after transient high glucose is caused by superoxide-dependent reduction in the bioavailability of NO and BH4 Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H626 - H633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Sigaudo-Roussel, C. Demiot, B. Fromy, A. Koitka, G. Leftheriotis, P. Abraham, and J. L. Saumet Early Endothelial Dysfunction Severely Impairs Skin Blood Flow Response to Local Pressure Application in Streptozotocin-Induced Diabetic Mice Diabetes, June 1, 2004; 53(6): 1564 - 1569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. I. Chisalita and H. J. Arnqvist Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E896 - E901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. R. DANESH and Y. S. KANWAR Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy FASEB J, May 1, 2004; 18(7): 805 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. A. Stehouwer Endothelial dysfunction in diabetic nephropathy: state of the art and potential significance for non-diabetic renal disease Nephrol. Dial. Transplant., April 1, 2004; 19(4): 778 - 781. [Full Text] [PDF]
|
|
|
|
|
|
Z. Bagi, A. Koller, and G. Kaley PPAR{gamma} activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H742 - H748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Hypertension, November 1, 2003; 42(5): 1050 - 1065. [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation, October 28, 2003; 108(17): 2154 - 2169. [Full Text] [PDF]
|
|
|
|
|
|
Z. Bagi, A. Koller, and G. Kaley Superoxide-NO interaction decreases flow- and agonist-induced dilations of coronary arterioles in Type 2 diabetes mellitus Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1404 - H1410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Wotherspoon, D. W Laight, K. M Shaw, and M. H Cummings Review: Homocysteine, endothelial dysfunction and oxidative stress in type 1 diabetes mellitus The British Journal of Diabetes & Vascular Disease, September 1, 2003; 3(5): 334 - 340. [Abstract] [PDF]
|
|
|
|
|
|
M. T. Schram, N. Chaturvedi, C. Schalkwijk, F. Giorgino, P. Ebeling, J. H. Fuller, and C. D. Stehouwer Vascular Risk Factors and Markers of Endothelial Function as Determinants of Inflammatory Markers in Type 1 Diabetes: The EURODIAB Prospective Complications Study Diabetes Care, July 1, 2003; 26(7): 2165 - 2173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Li, T. Sawamura, and G. Renier Glucose Enhances Endothelial LOX-1 Expression: Role for LOX-1 in Glucose-Induced Human Monocyte Adhesion to Endothelium Diabetes, July 1, 2003; 52(7): 1843 - 1850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Franklin, R. J. Ferry Jr., and P. Cohen Rapid Insulin-Like Growth Factor (IGF)-Independent Effects of IGF Binding Protein-3 on Endothelial Cell Survival J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 900 - 907. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Ramsay, R. J. Simms, W. R. Ferrell, L. Crawford, I. A. Greer, M.-A. Lumsden, and N. Sattar Enhancement of Endothelial Function by Pregnancy: Inadequate response in women with type 1 diabetes Diabetes Care, February 1, 2003; 26(2): 475 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. L Williams, A. Vazir, and A. G Zaman Review: The management of stable angina in diabetes The British Journal of Diabetes & Vascular Disease, January 1, 2003; 3(1): 18 - 25. [Abstract] [PDF]
|
|
|
|
|
|
D. Browne, D. Meeking, K. Shaw, and M. Cummings Review: Endothelial dysfunction and pre-symptomatic atherosclerosis in type 1 diabetes -- pathogenesis and identification The British Journal of Diabetes & Vascular Disease, January 1, 2003; 3(1): 27 - 34. [Abstract] [PDF]
|
|
|
|
 |
|
 L. E. Rabbani, N. A. Seminario, R. R. Sciacca, H. J. Chen, and E.-G. V. Giardina Oral conjugated equine estrogen increases plasma von Willebrand factor in postmenopausal women J. Am. Coll. Cardiol., December 4, 2002; 40(11): 1991 - 1999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C.B. Tan, W.-S. Chow, V. H.G. Ai, C. Metz, R. Bucala, and K. S.L. Lam Advanced Glycation End Products and Endothelial Dysfunction in Type 2 Diabetes Diabetes Care, June 1, 2002; 25(6): 1055 - 1059. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D.A. Stehouwer, M.-A. Gall, J. W.R. Twisk, E. Knudsen, J. J. Emeis, and H.-H. Parving Increased Urinary Albumin Excretion, Endothelial Dysfunction, and Chronic Low-Grade Inflammation in Type 2 Diabetes: Progressive, Interrelated, and Independently Associated With Risk of Death Diabetes, April 1, 2002; 51(4): 1157 - 1165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jager, V. W.M. van Hinsbergh, P. J. Kostense, J. J. Emeis, G. Nijpels, J. M. Dekker, R. J. Heine, L. M. Bouter, and C. D.A. Stehouwer C-Reactive Protein and Soluble Vascular Cell Adhesion Molecule-1 Are Associated With Elevated Urinary Albumin Excretion but Do Not Explain Its Link With Cardiovascular Risk Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 593 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P Garg and G. L Bakris Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease Vascular Medicine, February 1, 2002; 7(1): 35 - 43. [Abstract] [PDF]
|
|
|
|
|
|
K. C. B. Tan, W. S. Chow, S. C. F. Tam, V. H. G. Ai, C. H. L. Lam, and K. S. L. Lam Atorvastatin Lowers C-Reactive Protein and Improves Endothelium-Dependent Vasodilation in Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 563 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Perera, J.R. Petrie, C. Hillier, M. Small, N. Sattar, J.M.C. Connell, and M.A. Lumsden Hormone replacement therapy can augment vascular relaxation in post-menopausal women with type 2 diabetes Hum. Reprod., February 1, 2002; 17(2): 497 - 502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Rosengarten, A. Dost, A. Kaufmann, L. Gortner, and M. Kaps Impaired Cerebrovascular Reactivity in Type 1 Diabetic Children Diabetes Care, February 1, 2002; 25(2): 408 - 410. [Full Text]
|
|
|
|
 |
|
 A. I M Al-Shafei, R G Wise, G A Gresham, T A Carpenter, L D Hall, and C. L-H Huang Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition J. Physiol., January 15, 2002; 538(2): 555 - 572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Nicolaides and C. J. Jones Review: Type 2 diabetes -- implications for macrovascular mechanics and disease The British Journal of Diabetes & Vascular Disease, January 1, 2002; 2(1): 9 - 12. [Abstract] [PDF]
|
|
|
|
|
|
A. M.E. Spoelstra-de Man, C. B. Brouwer, C. D.A. Stehouwer, and Y. M. Smulders Rapid Progression of Albumin Excretion Is an Independent Predictor of Cardiovascular Mortality in Patients With Type 2 Diabetes and Microalbuminuria Diabetes Care, December 1, 2001; 24(12): 2097 - 2101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Pedrinelli, G. Dell'Omo, G. Penno, and M. Mariani Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease Vascular Medicine, November 1, 2001; 6(4): 257 - 264. [Abstract] [PDF]
|
|
|
|
|
|
M. Romano, M. Pomilio, S. Vigneri, A. Falco, P. L. Chiesa, F. Chiarelli, and G. Davi Endothelial Perturbation in Children and Adolescents With Type 1 Diabetes: Association with markers of the inflammatory reaction Diabetes Care, September 1, 2001; 24(9): 1674 - 1678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M Storey, C. J Perry, and J. R Petrie Review: Endothelial dysfunction in type 2 diabetes The British Journal of Diabetes & Vascular Disease, August 1, 2001; 1(1): 22 - 27. [Abstract] [PDF]
|
|
|
|
|
|
G. Booth, T. J. Stalker, A. M. Lefer, and R. Scalia Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin Am J Physiol Endocrinol Metab, June 1, 2001; 280(6): E848 - E856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jager, V. W. M. van Hinsbergh, P. J. Kostense, J. J. Emeis, G. Nijpels, J. M. Dekker, R. J. Heine, L. M. Bouter, and C. D. A. Stehouwer Prognostic implications of retinopathy and a high plasma von Willebrand factor concentration in type 2 diabetic subjects with microalbuminuria Nephrol. Dial. Transplant., March 1, 2001; 16(3): 529 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Calles-Escandon and M. Cipolla Diabetes and Endothelial Dysfunction: A Clinical Perspective Endocr. Rev., February 1, 2001; 22(1): 36 - 52. [Abstract] [Full Text]
|
|
|
|
|
|
R. Shurtz-Swirski, S. Sela, A. T. Herskovits, S. M. Shasha, G. Shapiro, L. Nasser, and B. Kristal Involvement of Peripheral Polymorphonuclear Leukocytes in Oxidative Stress and Inflammation in Type 2 Diabetic Patients Diabetes Care, January 1, 2001; 24(1): 104 - 110. [Abstract] [Full Text]
|
|
|
|
|
|
D.W. Laight, M.J. Carrier, and E.E. Anggard Antioxidants, diabetes and endothelial dysfunction Cardiovasc Res, August 18, 2000; 47(3): 457 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Dahlfors and H. J. Arnqvist Vascular Endothelial Growth Factor and Transforming Growth Factor-{beta}1 Regulate the Expression of Insulin-Like Growth Factor-Binding Protein-3, -4, and -5 in Large Vessel Endothelial Cells Endocrinology, June 1, 2000; 141(6): 2062 - 2067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Blann and G. Y. H. Lip Editorial: Cell Adhesion Molecules in Cardiovascular Disease and Its Risk Factors--What Can Soluble Levels Tell Us? J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1745 - 1747. [Full Text]
|
|
|
|
 |
|
 C. T. Valmadrid, R. Klein, S. E. Moss, and B. E. K. Klein The Risk of Cardiovascular Disease Mortality Associated With Microalbuminuria and Gross Proteinuria in Persons With Older-Onset Diabetes Mellitus Arch Intern Med, April 24, 2000; 160(8): 1093 - 1100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tanaka, M. Kurabayashi, Y. Aihara, Y. Ohyama, and R. Nagai Inducible Expression of Manganese Superoxide Dismutase by Phorbol 12-Myristate 13-Acetate Is Mediated by Sp1 in Endothelial Cells Arterioscler Thromb Vasc Biol, February 1, 2000; 20(2): 392 - 401. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hata, T. Yanagihara, H. Tanaka, C. Yamashiro, and K. Kanenishi Maternal ophthalmic artery Doppler velocimetry in type 1 diabetes during pregnancy Hum. Reprod., January 1, 2000; 15(1): 222 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jager, V. W. M. van Hinsbergh, P. J. Kostense, J. J. Emeis, J. S. Yudkin, G. Nijpels, J. M. Dekker, R. J. Heine, L. M. Bouter, and C. D. A. Stehouwer von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects : The Hoorn Study Arterioscler Thromb Vasc Biol, December 1, 1999; 19(12): 3071 - 3078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. WARPEHA, W. XU, L. LIU, I. G. CHARLES, C. C. PATTERSON, F. AH-FAT, S. HARDING, P. M. HART, U. CHAKRAVARTHY, and A. E. HUGHES Genotyping and functional analysis of a polymorphic (CCTTT)n repeat of NOS2A in diabetic retinopathy FASEB J, October 1, 1999; 13(13): 1825 - 1832. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. W. de Valk-de Roo, C. D.A. Stehouwer, J. Lambert, C. G. Schalkwijk, M. J. van der Mooren, C. Kluft, and C. Netelenbos Plasma Homocysteine Is Weakly Correlated with Plasma Endothelin and von Willebrand Factor but not with Endothelium-dependent Vasodilatation in Healthy Postmenopausal Women Clin. Chem., August 1, 1999; 45(8): 1200 - 1205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. NANNIPIERI, G. PENNO, L. PUCCI, H. COLHOUN, C. MOTTI, A. BERTACCA, L. RIZZO, L. DE GIORGIO, G. ZERBINI, R. MANGILI, et al. Pronatriodilatin Gene Polymorphisms, Microvascular Permeability, and Diabetic Nephropathy in Type 1 Diabetes Mellitus J. Am. Soc. Nephrol., July 1, 1999; 10(7): 1530 - 1541. [Abstract] [Full Text]
|
|
|
|
|
|
N. S Dhalla, X. Liu, V. Panagia, and N. Takeda Subcellular remodeling and heart dysfunction in chronic diabetes Cardiovasc Res, November 1, 1998; 40(2): 239 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jager, V. W.M. van Hinsbergh, P. J. Kostense, J. J. Emeis, G. Nijpels, J. M. Dekker, R. J. Heine, L. M. Bouter, and C. D.A. Stehouwer C-Reactive Protein and Soluble Vascular Cell Adhesion Molecule-1 Are Associated With Elevated Urinary Albumin Excretion but Do Not Explain Its Link With Cardiovascular Risk Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 593 - 598. [Abstract] [Full Text] [PDF]
|
|